Prelude Capital Management, LLC Bio Rad Laboratories, Inc. Transaction History

Prelude Capital Management, LLC

$1.5 Billion
Q4 2024

A detailed history of Prelude Capital Management, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 8,108 shares of BIO stock, worth $2.27 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

8,108

Previous 9,225 12.11%

Holding current value

$2.27 Million

Previous $3.09 Million 13.71%

% of portfolio

0.18%

Previous 0.2%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$313.15 - $374.28 $349,788 - $418,070	-1,117 Reduced 12.11%	8,108 $2.66 Million
Q3 2024 Nov 14, 2024	SELL	$263.97 - $344.64 $3.38 Million - $4.41 Million	-12,800 Reduced 58.12%	9,225 $3.09 Million
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $8.45 Million - $10.7 Million	-31,498 Reduced 58.85%	22,025 $6.02 Million
Q1 2024 May 15, 2024	BUY	$304.11 - $351.99 $1.21 Million - $1.4 Million	3,974 Added 8.02%	53,523 $18.5 Million
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $2.37 Million - $3.21 Million	8,794 Added 21.58%	49,549 $16 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $5.87 Million - $7.08 Million	16,762 Added 69.86%	40,755 $14.6 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $3.41 Million - $4.61 Million	9,477 Added 65.29%	23,993 $9.1 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $203,483 - $244,458	486 Added 3.46%	14,516 $6.95 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $3.46 Million - $4.48 Million	9,830 Added 234.05%	14,030 $5.9 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $324,295 - $442,722	786 Added 23.02%	4,200 $1.75 Million
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $1.58 Million - $2.04 Million	3,414 New	3,414 $1.69 Million
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $305,042 - $343,342	-529 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $289,368 - $350,383	529 New	529 $302,000
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $79,979 - $94,265	-176 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $4,353 - $6,409	13 Added 7.98%	176 $79,000
Q1 2020 May 15, 2020	SELL	$320.01 - $409.07 $77,762 - $99,404	-243 Reduced 59.85%	163 $57,000
Q4 2019 Feb 14, 2020	BUY	$319.73 - $374.2 $129,810 - $151,925	406 New	406 $150,000
Q1 2019 May 15, 2019	SELL	$224.3 - $317.41 $233,272 - $330,106	-1,040 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $179,601 - $252,144	816 Added 364.29%	1,040 $242,000
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $818,373 - $922,678	-2,829 Reduced 92.66%	224 $70,000
Q2 2018 Aug 14, 2018	BUY	$244.1 - $303.88 $163,547 - $203,599	670 Added 28.12%	3,053 $881,000
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $1.13 Million - $1.33 Million	-4,839 Reduced 67.0%	2,383 $596,000
Q4 2017 Feb 14, 2018	SELL	$216.94 - $271.3 $675,334 - $844,556	-3,113 Reduced 30.12%	7,222 $1.72 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $2.19 Million - $2.5 Million	10,335	10,335 $2.3 Million

Others Institutions Holding BIO

# of Institutions

477

Shares Held

19.2M

Call Options Held

15.7K

Put Options Held

11.5K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.9B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Bio Rad Laboratories, Inc. Transaction History